Summary
Microchip Technology Inc. (MCHP) reported strong financial results for the quarter ended June 30, 2021, driven by robust demand across its semiconductor product lines. Net sales increased by 19.8% year-over-year to $1.57 billion, with significant growth in Microcontrollers and Analog products. The company maintained a healthy gross profit margin of 64.2%, an improvement from 61.0% in the prior year, benefiting from increased capacity utilization and favorable product mix. Operating income saw substantial growth, increasing from $218.3 million to $368.8 million. Despite persistent supply chain constraints expected to continue through mid-2022, Microchip demonstrated strong operational execution. The company generated robust operating cash flow of $629.9 million, supporting investments in capital expenditures, which increased to $86.3 million to expand production capacity. The balance sheet remains solid, with total assets of $16.28 billion and total liabilities and stockholders' equity of $16.28 billion. The company also continues to return capital to shareholders through dividends.
Financial Highlights
56 data points| Revenue | $1.57B |
| Cost of Revenue | $561.80M |
| Gross Profit | $1.01B |
| R&D Expenses | $238.40M |
| SG&A Expenses | $174.30M |
| Operating Expenses | $638.80M |
| Operating Income | $368.80M |
| Interest Expense | $72.30M |
| Net Income | $252.80M |
| EPS (Basic) | $0.46 |
| EPS (Diluted) | $0.45 |
| Shares Outstanding (Basic) | 547.50M |
| Shares Outstanding (Diluted) | 565.10M |
Key Highlights
- 1Net sales increased 19.8% year-over-year to $1.57 billion, driven by strong demand in microcontroller and analog product lines.
- 2Gross profit margin improved to 64.2% from 61.0% in the prior year, attributed to higher capacity utilization and favorable product mix.
- 3Operating income significantly increased by 68.7% to $368.8 million.
- 4Net income more than doubled to $252.8 million, resulting in diluted EPS of $0.89, up from $0.48 in the prior year.
- 5Operating cash flow remained strong at $629.9 million, reflecting healthy cash generation.
- 6Capital expenditures increased to $86.3 million, reflecting investments in production capacity expansion.
- 7Supply chain constraints are expected to persist through mid-calendar 2022, but the company is actively managing capacity.